Aridis Pharmaceuticals (ARDS) Stock Chart & Stock Price History → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free ARDS Stock Alerts $0.06 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Aridis Pharmaceuticals Stock Price Performance5 Day Performance+0.78%1 Month Performance-13.04%3 Month Performance-13.95%6 Month Performance-24.86%Year-To-Date Performance-7.28%1 Year Performance-65.63% Receive ARDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> ARDS Stock Chart for Saturday, April, 27, 2024 ARDS Chart by TradingView Aridis Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$0.07$0.07$0.07$0.0624,355 shs$3.12 million04/25/2024$0.06$0.07+3.17%$0.07$0.067,762 shs$3.12 million04/24/2024$0.06$0.06-0.79%$0.07$0.0629,800 shs$3.02 million04/23/2024$0.06$0.06-1.55%$0.06$0.06148,984 shs$3.04 million04/22/2024$0.06$0.06+7.50%$0.07$0.0641,399 shs$3.09 million04/19/2024$0.06$0.06-2.48%$0.07$0.06113,915 shs$2.88 million Get the Latest News and Ratings for ARDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.07$0.06-6.78%$0.06$0.06407,922 shs$2.95 million04/17/2024$0.07$0.07-6.38%$0.07$0.0627,515 shs$3.16 million04/16/2024$0.07$0.07+0.71%$0.08$0.0719,512 shs$3.38 million04/15/2024$0.07$0.07-2.43%$0.07$0.07101,210 shs$3.36 million04/12/2024$0.07$0.07-2.36%$0.07$0.0737,003 shs$3.44 million04/11/2024$0.07$0.07+9.34%$0.08$0.07163,046 shs$3.52 million04/10/2024$0.07$0.07-1.18%$0.08$0.0769,150 shs$3.22 million04/09/2024$0.08$0.07-11.11%$0.08$0.0744,173 shs$3.26 million04/08/2024$0.07$0.08+6.99%$0.08$0.0748,915 shs$3.67 million04/05/2024$0.07$0.07-0.14%$0.08$0.07109,471 shs$3.43 million04/04/2024$0.07$0.07-1.92%$0.08$0.0728,087 shs$3.43 million04/03/2024$0.07$0.07+2.10%$0.08$0.0710,153 shs$3.50 million04/02/2024$0.07$0.07$0.08$0.0757,203 shs$3.43 million04/01/2024$0.08$0.07-8.33%$0.08$0.0757,203 shs$3.43 million03/29/2024$0.08$0.08$0.08$0.0718,884 shs$3.74 million03/28/2024$0.07$0.08+4.35%$0.08$0.0718,884 shs$3.74 million03/27/2024$0.07$0.07+0.88%$0.07$0.0735,280 shs$3.58 million03/26/2024$0.08$0.07-4.88%$0.08$0.075,811 shs$3.55 million03/25/2024$0.08$0.08-0.13%$0.08$0.0743,010 shs$3.73 million03/22/2024$0.07$0.07$0.08$0.0789,623 shs$3.55 million03/21/2024$0.07$0.07+1.37%$0.07$0.0789,623 shs$3.55 million03/20/2024$0.08$0.07-8.64%$0.08$0.0731,336 shs$3.50 million03/19/2024$0.08$0.08+6.53%$0.08$0.0747,709 shs$3.83 million03/18/2024$0.08$0.08-6.25%$0.08$0.07153,822 shs$3.60 million03/15/2024$0.08$0.08$0.09$0.08102,209 shs$4.03 million03/14/2024$0.08$0.08+9.45%$0.08$0.08102,209 shs$4.03 million03/13/2024$0.08$0.08-4.06%$0.08$0.0729,354 shs$3.68 million03/12/2024$0.08$0.08+2.56%$0.08$0.0735,870 shs$3.83 million03/11/2024$0.08$0.08$0.08$0.0713,191 shs$3.74 million03/08/2024$0.08$0.08+2.28%$0.08$0.0710,585 shs$3.74 million03/07/2024$0.07$0.08+5.92%$0.08$0.07218,651 shs$3.66 million03/06/2024$0.07$0.07$0.08$0.0772,936 shs$3.45 million03/05/2024$0.07$0.07-0.69%$0.08$0.0772,936 shs$3.45 million03/04/2024$0.07$0.07-2.03%$0.08$0.0748,302 shs$3.48 millionThey say it’s ‘unstoppable’ – How I made 43,509% (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story.03/01/2024$0.08$0.07-4.15%$0.08$0.072,866 shs$3.55 million02/29/2024$0.08$0.08+0.26%$0.08$0.0742,058 shs$3.70 million02/28/2024$0.08$0.08+2.67%$0.08$0.0737,418 shs$3.69 million02/27/2024$0.07$0.08+5.63%$0.08$0.0738,662 shs$3.60 million02/26/2024$0.08$0.07-5.33%$0.08$0.0776,962 shs$3.40 million02/23/2024$0.08$0.08-3.72%$0.08$0.07249,797 shs$3.60 million02/22/2024$0.07$0.08+4.56%$0.08$0.07157,589 shs$3.73 million02/21/2024$0.08$0.07-3.25%$0.08$0.0790,952 shs$3.57 million02/20/2024$0.07$0.08+9.84%$0.08$0.0729,768 shs$3.69 million02/19/2024$0.07$0.07$0.08$0.0756,500 shs$3.36 million02/16/2024$0.07$0.07-4.76%$0.08$0.0756,585 shs$3.36 million02/15/2024$0.07$0.07-0.14%$0.08$0.0729,120 shs$3.53 million02/14/2024$0.07$0.07+0.27%$0.08$0.0757,705 shs$3.53 million02/13/2024$0.07$0.07+5.15%$0.07$0.0767,513 shs$3.52 million02/12/2024$0.07$0.07-0.14%$0.07$0.0789,735 shs$3.35 million02/09/2024$0.07$0.07-2.20%$0.07$0.0727,066 shs$3.36 million02/08/2024$0.07$0.07+1.67%$0.08$0.0747,772 shs$3.43 million02/07/2024$0.08$0.07-9.74%$0.08$0.0775,536 shs$3.37 million02/06/2024$0.07$0.08+10.56%$0.08$0.0714,984 shs$3.74 million02/05/2024$0.08$0.07-10.87%$0.08$0.07469,764 shs$3.38 million02/02/2024$0.07$0.08+10.39%$0.08$0.0751,687 shs$3.59 million02/01/2024$0.07$0.07+2.21%$0.08$0.0794,397 shs$3.25 million01/31/2024$0.07$0.07+1.67%$0.08$0.07133,668 shs$3.18 million01/30/2024$0.07$0.07$0.09$0.07813,580 shs$3.13 million01/29/2024$0.08$0.07-8.66%$0.08$0.0773,582 shs$3.13 million01/26/2024$0.07$0.08+11.09%$0.08$0.0740,251 shs$3.43 million Related Companies: GOVX Stock Price Chart PHAS Stock Price Chart NEXI Stock Price Chart BCEL Stock Price Chart SXTP Stock Price Chart PHIO Stock Price Chart MBIO Stock Price Chart ARAV Stock Price Chart RNAZ Stock Price Chart NBY Stock Price Chart Receive ARDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARDS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aridis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.